COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,673 Articles (22,913 medRxiv, 8,760 bioRxiv)

Most recent first Previous |  Page 1195: Articles 11941-11950  | Next

Efficacy and Safety of SOBERANA 02, a COVID-19 conjugate vaccine in heterologous three doses combination
Toledo-Romani, M. E., Garcia-Carmenate, M., Valenzuela Silva, C., Baldoquin-Rodriguez, W., Martinez Perez, M., Rodriguez Gonzalez, M. C., Paredes Moreno, B., Mendoza Hernandez, I., Gonzalez-Mujica Romero, R., Samon Tabio, O., Velazco Villares, P., Bacallao Castillo, J. P., Licea Martin, E., Rodriguez Ortega,, M., Herrera Marrero, N. L., Caballero Gonzalez, E., Egues Torres, L. I., Duarte Gonzalez, R., Garcia Blanco, S., Perez Cabrera, S., Huete Ferreira, S., Idalmis Cisnero, K. I., Fonte Galindo, O., Melia Perez, D., Rojas Remedios, I., Fernandez Castillo, S., Climent Ruiz, Y., Valdes Balbin, Y., Garcia Rivera, D., Verez-Bencomo, v.
10.1101/2021.10.31.21265703 — Posted: 2021-11-01
Structure-function analysis of the nsp14 N7-guanine methyltransferase reveals an essential role in Betacoronavirus replication
Ogando, N. S., El Kazzi, P., Zevenhoven-Dobbe, J. C., Bontes, B. w., Decombe, A., Posthuma, C. C. S., Thiel, V., Canard, B., Ferron, F., Decroly, E., Snijder, E. J.
10.1101/2021.05.17.444407 — Posted: 2021-11-01
Predictors of COVID testing among Australian youth: Insights from the Longitudinal Study of Australian Children
Islam, M. I., Chadwick, V., Martiniuk, A.
10.1101/2021.10.31.21265627 — Posted: 2021-11-01
Quantifying the effects of non-pharmaceutical and pharmaceutical interventions against COVID-19 epidemic in the Republic of Korea: Mathematical model-based approach considering age groups and the Delta variant
Ko, Y., Mendoza, V. M. P., Seo, Y., Lee, J., Kim, Y., Kwon, D., Jung, E.
10.1101/2021.11.01.21265729 — Posted: 2021-11-01
Modelling COVID-19 Pandemic Dynamics Using Transparent, Interpretable, Parsimonious and Simulatable (TIPS) Machine Learning Models: A Case Study from Systems Thinking and System Identification Perspectives
Wei, H.-L., Billings, S. A.
10.1101/2021.11.01.21265653 — Posted: 2021-11-01
Underlying factors that influence the acceptance of COVID-19 vaccine in a country with a high vaccination rate
Toro-Ascuy, D., Cifuentes-Munoz, N., Avaria, A., Pereira-Montecinos, C., Cruzat, G., Zorondo-Rodriguez, F., Fuenzalida, L. F.
10.1101/2021.10.31.21265676 — Posted: 2021-11-01
Serological Response to BNT162b2 and ChAdOx1 nCoV-19 Vaccines in Patients with Inflammatory Bowel Disease on Biologic Therapies; A Multi-Center Prospective Study
Shehab, M., Alrashed, F., Alfadhli, A., Alotaibi, K., Alsahli, A., Mohammad, H., Cherian, P., Alkhairi, I., Thanaraj, T. A., Channanath, A., Ali, H., Abu-farha, M., Abubaker, J., Al-Mulla, F.
10.1101/2021.10.31.21265718 — Posted: 2021-11-01
Heterogenous pattern of the inflammasome-related markers in the critically ill COVID-19 patients at the ICU admission.
Adamik, B., Ambrozek-Latecka, M., Dragan, B., Jeznach, A., Smiechowicz, J., Gozdzik, W., Skirecki, T.
10.1101/2021.10.30.21265662 — Posted: 2021-11-01
Azithromycin consumption during the COVID-19 pandemic in Croatia, 2020
Bogdanic, N., Mocibob, L., Vidovic, T., Soldo, A., Begovac, J.
10.1101/2021.10.31.21265714 — Posted: 2021-11-01
Automated Interpretable Discovery of Heterogeneous Treatment Effectiveness: A Covid-19 Case Study
Lengerich, B. J., Nunnally, M. E., Aphinyanaphongs, Y. J., Caruana, R.
10.1101/2021.10.30.21265430 — Posted: 2021-11-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).